β-Adrenoceptor-mediated inhibition of IFN-γ, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the β2-Adrenoceptor subtype

American Journal of Respiratory Cell and Molecular Biology

Volumn 19, Issue 3, 1998, Pages 400-407

  Borger, Peter ^a   Hoekstra, Yke ^a   Esselink, Mariet T ^a   Postma, Dirkje S ^a   Zaagsma, Johan ^a   Vellenga, Edo ^a   Kauffman, Henk F ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; BETA 2 ADRENERGIC RECEPTOR; CONCANAVALIN A; CYCLIC AMP; ETHANOLAMINE DERIVATIVE; FENOTEROL; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 4; ISOPRENALINE; MESSENGER RNA; TIMOLOL;

ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; T LYMPHOCYTE;

CONCANAVALIN A; CYCLIC AMP; ETHANOLAMINES; FENOTEROL; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON TYPE II; INTERLEUKIN-3; INTERLEUKIN-4; ISOPROTERENOL; RECEPTORS, ADRENERGIC, BETA-2; RNA, MESSENGER; T-LYMPHOCYTES; TIMOLOL;

EID: 0032159216     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.19.3.2765     Document Type: Article

References (33)

1. Spengler, R. N., S. W. Chensue, D. A. Giacherio, N. Blenk, and S. L. Kunkel. 1994. Endogenous norepinephrine regulates tumor necrosis factor-α production from macrophages in vitro. J. Immunol. 152:3024-3031.
2. Dokter, W. H. A., M. T. Esselink, S. J. Sierdsema, M. R. Halie, and E. Vellenga. 1993. Transcriptional and post-transcriptional regulation of the interleukin-4 and interleukin-3 genes in human T-cells. Blood 81:35-40.
3. Schwarz, R. H. 1992. Costimulation of T-lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin 2 production and immunotherapy. Cell 71:1065-1068.
4. Borger, P., H. F. Kauffman, D. S. Postma, and E. Vellenga. 1996. IL-7 differentially modulates the expression of IFN-γ and IL-4 in activated human T lymphocytes by transcriptional and post-transcriptional mechanisms. J. Immunol. 156:1333-1338.
5. Borger, P., M. F. Kauffman, D. S. Postma, and E. Vellenga. 1996. Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway. Blood 87:691-698.
6. Borger, P., J. M. J. Vijgen, H. F. Kauffman, D. S. Postma, and E. Vellenga. 1996. Activation of the cAMP dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte/macrophage colony-stimulating factor in activated human T-lymphocytes. Exp. Hematol. 24:108-115.
7. Bourne, H. R., L. M. Lichtenstein, K. L. Melmon, C. S. Henney, Y. Weinstein, and G. M. Shearer. 1974. Modulation of inflammation and immunity by cyclic AMP. Science 184:19-28.
8. Rappaport, R. S., and G. R. Dodge. 1982. Prostaglandin E inhibits the production of human interleukin 2. J. Exp. Med. 155:943-948.
9. Novak, T. J., and E. V. Rothenberg. 1990. cAMP inhibits the expression of interleukin 2 but not of interleukin 4 in T cells. Proc. Natl. Acad. Sci. USA 87:9353-9357.
10. Emorine, L. J., S. Marullo, M. M. Briend-Sutren, G. Patey, K. Tate, C. Delavier-Klutchko, and A. D. Strosberg. 1989. Molecular characterization of the human β3-adrenergic receptor. Science 245:1118-1121.
11. Lefkowitz, R. J., J. M. Stadel, and M. G. Caron. 1983. Adenylyl cyclase coupled beta-adrenergic receptors: structure and mechanism of activation and desensitization. Annu. Rev. Biochem. 52:159-186.
12. Griese, M., U. Korholz, D. Korholz, K. Seeger, V. Wahn, and D. Reinhardt. 1988. Density and agonist-promoted high and low affinity states of the β-adrenoceptor on human B and T-cells. Eur. J. Clin. Invest. 18:213-217.
13. Landmann, R. 1992. Beta-adrenergic receptors in human leukocyte subpopulations. Eur. J. Clin. Invest. 22(Suppl. 1):30-36.
14. Paegelow, I., and H. Werner. 1987. Influence of adrenergic agonists and antagonists on lymphokine secretion in vitro. Int. J. Immunopharmacol. 9: 761-768.
15. Betz, M., and B. S. Fox. 1991. Prostaglandin E2 inhibits the production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146:108-113.
16. Muñoz, E., A. M. Zubiaga, M. Merrow, N. P. Sauter, and B. T. Huber. 1990. Cholera toxin discriminates between Th1 and 2 cell receptor mediated activation: role of cAMP in T cell proliferation. J. Exp. Med. 172:95-103.
17. Snijdewint, F. G. M., P. Kalinski, E. A. Wierenga, J. D. Bos, and M. L. Kapsenberg. 1993. Prostaglandin E2 differentially modulates secretion profiles of human T helper lymphocytes. J. Immunol. 150:5321-5329.
18. Meurs, H., G. H. Koëter, K. de Vries, and H. F. Kauffman. 1982. The beta-adrenergic system and allergic bronchial asthma: changes in lymphocyte beta-adrenergic receptor number and adenylyl cyclase activity after an allergen induced attack. J. Allergy Clin. Immunol. 70:272-280.
19. Ying, S., S. R. Durham, C. J. Corrigan, O. Hamid, and B. Kay. 1995. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon γ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am. J. Respir. Cell Mol. Biol. 12:477-487.
20. 3-adrenoceptor? TIPS 11:3-7.
21. Hollenga, C., F. Brouwer, and J. Zaagsma. 1991. Differences in functional cyclic AMP compartments mediating lipolysis by non-selective agonists in four adipocyte types. Eur. J. Pharmacol. 200:325-330.
22. Vellenga, E., A. Rambaldi, T. J. Ernst, D. Ostapovicz, and J. D. Griffin. 1988. Independent regulation of M-CSF and G-CSF gene expression in human monocytes. Blood 71:1529-1532.
23. Maniatis, T., E. F. Fritsch, and A. Sambrook. 1982. Molecular Cloning - A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
24. Feinberg, A. P., and B. Vogelstein. 1983. A technique for labeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13.
25. Meurs, H., H. F. Kauffman, G. Koëter, and K. de Vries. 1980. Extraction of cyclic AMP for the determination in the competitive protein binding assay. Clin. Chim. Acta 106:91-97.
26. 2 and affinity constants for pharmacological competitive antagonists be estimated? J. Pharm. Pharmacol. 30:312-313.
27. Bishopric, N. H., H. J. Cohen, and R. J. Lefkowitz. 1980. Beta-adrenergic receptors in lymphocyte subpopulations. J. Allergy Clin. Immunol. 65:29-33.
28. Dailey, M. O., J. Schreurs, and H. Schulman. 1988. Hormone receptors on cloned T lymphocytes. J. Immunol. 140:2931-2936.
29. Nijkamp, F. P., F. Engels, P. A. Hendricks, and A. J. M. van Oosterhout. 1992. Mechanisms of β-adrenergic receptor regulation in lungs and its implications for physiological responses. Physiol. Rev. 72:323-367.
30. Arch, J. R. S., A. T. Ainsworth, M. A. Cawthorne, V. Piercy, M. V. Sennit, V. E. Thody, C. Wilson, and S. Wilson. 1984. Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 309:163-165.
31. Zaagsma, J., L. Meems, and M. Boorsma. 1977. Influence of albumin on in vitro β-adrenoceptor blocking and anliarrhythmic properties of propranolol, pindolol, practolol and metoprolol. Naunyn-Schmiedeberg's Arch. Pharmacol. 298:29-36.
32. Hollenga, C., M. Haas, J. T. Deinum, and J. Zaagsma. 1991. Differences in functional cyclic AMP mediating lipolysis by isoprenaline and BRL 37344 in four adipocyte types. Eur. J. Pharmacol 200:325-330.
33. Dooper, M. W. S. M., A. Timmermans, E. J. M. Weersink, J. G. R. de Monchy, and H. F. Kauffman. 1995. Defect in potentiation of adenylyl cyclase correlates with bronchial hyperreactivity. J. Allergy Clin. Immunol. 96: 628-634.